search
Back to results

Effectiveness of a Structured Intervention to Reduce the Progression of Chronic Kidney (RENAP Study) (RENAP)

Primary Purpose

Renal Insufficiency Chronic

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Structured intervention
Sponsored by
Gerencia de Atención Primaria, Madrid
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Renal Insufficiency Chronic focused on measuring Glomerular filtration Rate., Primary Health Care., Cluster Clinical Trial.

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients 18 years of age or older
  • Willing and able to give informed consent for participation in the study.
  • Ability to understand study procedures and to comply with them for the entire length of the study.
  • Registered episode on electronic medical records in Primary Care with the diagnosis of Chronic Kidney Disease (CKD) stage 3 or confirmation of CKD by a second blood sample in risk patients with suspected CKD( owing to a blood sample taken at least three months before

Exclusion Criteria:

  • Inability or unwillingness to give written informed consent.
  • Severe psychiatric conditions including depression and major affective disorders registered on medical records.
  • Disabled and unable to attend Health Centre.
  • Severe CKD, defined as glomerular filtration rate (GFR) < 30 ml/min/1,73m2.
  • Patients undergoing dialysis or kidney transplantation.
  • Patients hemodynamically unstable with impaired kidney function (Eg. Cardiac Failure, unstable angina pectoris).
  • Acute kidney failure.
  • Patients with an episode of impaired kidney perfusion on the last month (Eg. Severe hemorrhage, burns, dehydration, major trauma).

Sites / Locations

  • Gerencia Atencion Primaria

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Active Comparator

Arm Label

Control

Structured intervention

Arm Description

There is not intervention in this group.

Initial training session based on significant learning and follow up visits every four months at physicians and nurses´ offices over a two-year period

Outcomes

Primary Outcome Measures

Creatinine clearance
Glomerular filtration rate measured by Modification of Diet in Renal Disease (MDRD)formula and expressed in ml/min. The MDRD formula estimates the glomerular filtrate through the levels of creatinine plasma, sex and age.

Secondary Outcome Measures

Full Information

First Posted
June 3, 2013
Last Updated
April 10, 2015
Sponsor
Gerencia de Atención Primaria, Madrid
Collaborators
Instituto de Salud Carlos III
search

1. Study Identification

Unique Protocol Identification Number
NCT01872468
Brief Title
Effectiveness of a Structured Intervention to Reduce the Progression of Chronic Kidney (RENAP Study)
Acronym
RENAP
Official Title
Effectiveness of an Structured Intervention in Patients With Chronic Kidney Failure to Reduce the Progression of the Illness.
Study Type
Interventional

2. Study Status

Record Verification Date
April 2015
Overall Recruitment Status
Completed
Study Start Date
September 2011 (undefined)
Primary Completion Date
January 2014 (Actual)
Study Completion Date
January 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Gerencia de Atención Primaria, Madrid
Collaborators
Instituto de Salud Carlos III

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The propose of study is to study if an informative intervention and a structured follow-up carried out in health centres of primary care in patients with chronic kidney failure, stage 3, is more effective than the current follow-up in slowing the disease progression measured by the glomerular filtration rate.
Detailed Description
Main objective: To study if an informative intervention and a structured follow-up carried out in health centres of primary care in patients with chronic kidney failure, stages 3, is more effective than the current follow-up in slowing the disease progression measured by the glomerular filtration rate . Secondary objectives: Determining the effectiveness of the intervention to improve the blood pressure control of the patients with chronic kidney failure and to improve the degree of control of the glucose levels and glycosylated haemoglobin of the diabetic patients with chronic kidney failure. Design: A clinical trial controlled with a random assignment by conglomerates with parallel groups. Setting: Multi-centre study in Primary Care Health Centres(Madrid Health Service). Subjects of the study: 540 patients over 18 years old, diagnosed of light-moderate chronic kidney failure that consent to participate. Data collection: The variable of the main answer will be the creatinine clearance measured in ml/min. Demographic variables of morbidity and prognosis: clinical, analytical, anthropometrical, adherence to processing and consumption of medicines will be collected. Intervention: Initial educational session based on the significant learning and quarterly follow-up in surgery of medicine and nursing for 2 years. Analysis: By intention of treating. Descriptive statistics of each variable and statistical analytical univariate and multivariate (multiple linear regression) will be carried out. The explanatory variable in the analysis multivariate will be the intervention group.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Renal Insufficiency Chronic
Keywords
Glomerular filtration Rate., Primary Health Care., Cluster Clinical Trial.

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
269 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
No Intervention
Arm Description
There is not intervention in this group.
Arm Title
Structured intervention
Arm Type
Active Comparator
Arm Description
Initial training session based on significant learning and follow up visits every four months at physicians and nurses´ offices over a two-year period
Intervention Type
Behavioral
Intervention Name(s)
Structured intervention
Intervention Description
Initial training session based on patient personal experiences and reflexion (30 minutes). CKD learning session (30 minutes). Personal plan of actions to cope with own disease (30 minutes. Discussion of doubts (30 minutes). Follow up visits every four months at physicians and nurses´ offices over a two-year period
Primary Outcome Measure Information:
Title
Creatinine clearance
Description
Glomerular filtration rate measured by Modification of Diet in Renal Disease (MDRD)formula and expressed in ml/min. The MDRD formula estimates the glomerular filtrate through the levels of creatinine plasma, sex and age.
Time Frame
2 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients 18 years of age or older Willing and able to give informed consent for participation in the study. Ability to understand study procedures and to comply with them for the entire length of the study. Registered episode on electronic medical records in Primary Care with the diagnosis of Chronic Kidney Disease (CKD) stage 3 or confirmation of CKD by a second blood sample in risk patients with suspected CKD( owing to a blood sample taken at least three months before Exclusion Criteria: Inability or unwillingness to give written informed consent. Severe psychiatric conditions including depression and major affective disorders registered on medical records. Disabled and unable to attend Health Centre. Severe CKD, defined as glomerular filtration rate (GFR) < 30 ml/min/1,73m2. Patients undergoing dialysis or kidney transplantation. Patients hemodynamically unstable with impaired kidney function (Eg. Cardiac Failure, unstable angina pectoris). Acute kidney failure. Patients with an episode of impaired kidney perfusion on the last month (Eg. Severe hemorrhage, burns, dehydration, major trauma).
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marta Sánchez-Celaya, Doctor
Organizational Affiliation
Gerencia Atención Primaria. Madrid
Official's Role
Principal Investigator
Facility Information:
Facility Name
Gerencia Atencion Primaria
City
Madrid
ZIP/Postal Code
28033
Country
Spain

12. IPD Sharing Statement

Learn more about this trial

Effectiveness of a Structured Intervention to Reduce the Progression of Chronic Kidney (RENAP Study)

We'll reach out to this number within 24 hrs